MKM Partners Downgrades Nektar Therapeutics (NKTR) to Neutral

February 27, 2014 7:21 AM

MKM Partners downgraded Nektar Therapeutics (NASDAQ: NKTR) from Buy to Neutral with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found